We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Zomedica Corp | AMEX:ZOM | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.0027 | 1.90% | 0.1447 | 0.1489 | 0.1371 | 0.142 | 8,812,955 | 01:00:00 |
Chief Financial Officer Shameze Rampertab, CPA, CA, will provide an overview of Zomedica’s business during his presentations and will be available to participate in one-on-one meetings with investors invited to attend each conference.
LD Micro NYC Summit
The LD Micro NYC Summit is an invite-only event. Interested parties should contact david@ldmicro.com for further information.
Cantor Global Healthcare Conference
Date: Tuesday, October 2, 2018Time: 4:35 p.m. ETLocation: InterContinental New York Barclay Hotel, New York, NY
Webcast Information: Investors and other interested parties will be able to access a live webcast of the presentation by visiting Zomedica’s website at http://www.zomedica.com/investor-information/events-presentations/. A replay of the audio webcast and copies of the presentation will be accessible on the Zomedica website following the event.
About ZomedicaBased in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) (TSX-V:ZOM) is a veterinary diagnostic and pharmaceutical company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.
Follow Zomedica
Reader AdvisoryNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
Investor Relations ContactsShameze Rampertab, CPA, CAsrampertab@zomedica.com+1 647.283.3630
PCG Advisory GroupKirin Smith, COOksmith@pcgadvisory.com+1 646.863.6519www.pcgadvisory.com
Media ContactAndrea Eberleaeberle@zomedica.com+1 734.369.2555
1 Year Zomedica Chart |
1 Month Zomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions